FI874406A7 - Förfarande för framställning av terapeutiskt användbara cyklodextrinklatrat av en karbacyklinanalog - Google Patents

Förfarande för framställning av terapeutiskt användbara cyklodextrinklatrat av en karbacyklinanalog

Info

Publication number: FI874406A7
Authority: FI; Finland
Prior art keywords: carbacycline; analogues; therapeutically useful; cyclodextrin clathrates; preparing therapeutically
Prior art date: 1986-03-07

Application number

FI874406A

Other languages

English (en)

Finnish (fi)

Other versions

FI874406A0 (sv

FI92388B (sv

FI92388C (sv

Inventor

Werner Skuballa

Helmut Vorbrueggen

Helmut Dahl

Claus-Steffen Stuerzebecher

Karl-Heinz Thierauch

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-03-07

Filing date

1987-10-07

Publication date

1987-10-07

1987-10-07 Application filed by Schering Ag filed Critical Schering Ag

1987-10-07 Publication of FI874406A0 publication Critical patent/FI874406A0/sv

1987-10-07 Publication of FI874406A7 publication Critical patent/FI874406A7/sv

1994-07-29 Publication of FI92388B publication Critical patent/FI92388B/sv

1994-11-10 Application granted granted Critical

1994-11-10 Publication of FI92388C publication Critical patent/FI92388C/sv

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/005—Analogues or derivatives having the five membered ring replaced by other rings
- C07C405/0075—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
- C07C405/0083—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Nanotechnology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Epidemiology (AREA)
Crystallography & Structural Chemistry (AREA)
Medical Informatics (AREA)
Biochemistry (AREA)
Materials Engineering (AREA)
Polymers & Plastics (AREA)
Biophysics (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Medicinal Preparation (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

FI874406A 1986-03-07 1987-10-07 Förfarande för framställning av terapeutiskt användbara cyklodextrinklatrat av en karbacyklinanalog FI92388C (sv)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DE3608088A DE3608088C2 (de)	1986-03-07	1986-03-07	Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3608088		1986-03-07
DE8700106		1987-03-09
PCT/DE1987/000106 WO1987005294A1 (fr)	1986-03-07	1987-03-09	Cyclodextrineclathrates de derives de carbacycline et leur utilisation comme medicaments

Publications (4)

Publication Number	Publication Date
FI874406A0 FI874406A0 (sv)	1987-10-07
FI874406A7 true FI874406A7 (sv)	1987-10-07
FI92388B FI92388B (sv)	1994-07-29
FI92388C FI92388C (sv)	1994-11-10

Family

ID=6296073

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI874406A FI92388C (sv)	1986-03-07	1987-10-07	Förfarande för framställning av terapeutiskt användbara cyklodextrinklatrat av en karbacyklinanalog

Country Status (22)

Country	Link
US (1)	US4886788A (sv)
EP (1)	EP0259468B1 (sv)
JP (2)	JPH07107020B2 (sv)
AT (1)	AT397084B (sv)
AU (2)	AU6988687A (sv)
CA (1)	CA1309087C (sv)
CH (1)	CH672313A5 (sv)
CS (1)	CS270558B2 (sv)
DD (1)	DD258942A5 (sv)
DE (3)	DE3608088C2 (sv)
ES (1)	ES2004543A6 (sv)
FI (1)	FI92388C (sv)
GB (2)	GB2189783A (sv)
GR (1)	GR870363B (sv)
HU (1)	HU198906B (sv)
IE (1)	IE59760B1 (sv)
IL (1)	IL81802A (sv)
NO (1)	NO173440C (sv)
NZ (1)	NZ219508A (sv)
SU (1)	SU1632371A3 (sv)
WO (1)	WO1987005294A1 (sv)
ZA (1)	ZA871663B (sv)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4663316A (en) *	1985-06-28	1987-05-05	Warner-Lambert Company	Antibiotic clathrates and pharmaceutical compositions thereof
DE3608088C2 (de) *	1986-03-07	1995-11-16	Schering Ag	Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3740838A1 (de) *	1987-11-27	1989-06-08	Schering Ag	Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel
ATE122563T1 (de) *	1989-07-27	1995-06-15	Ueno Seiyaku Oyo Kenkyujo Kk	Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
DE3933523A1 (de) *	1989-10-05	1991-04-11	Schering Ag	Antimetastatisch wirkende mittel
DE4010355A1 (de) *	1990-03-28	1991-10-02	Schering Ag	Bicyclo(3.3.0)octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE4104606C1 (sv) *	1991-02-12	1992-10-15	Schering Ag Berlin Und Bergkamen, 1000 Berlin, De
US5221735A (en) *	1991-02-25	1993-06-22	Hoffmann-La Roche Inc.	Cyclodextrin-polyene inclusion complexes
DE4135193C1 (sv) *	1991-10-22	1993-03-11	Schering Ag Berlin Und Bergkamen, 1000 Berlin, De
US6103403A (en) *	1997-05-15	2000-08-15	University Of Kentucky Research Foundation Intellectual Property Development	Clathrate structure for electronic and electro-optic applications
DE19808634A1 (de)	1998-02-24	1999-08-26	Schering Ag	Mantel für eine pharmazeutische Zusammensetzung
DE19828881A1 (de)	1998-06-22	1999-12-23	Schering Ag	Oxidationsinhibitor bei Prostan-Derivaten
DE10225551A1 (de) *	2002-06-06	2003-12-24	Schering Ag	Verwendung von oral verfügbaren Prostacyclinderivaten für die Herstellung eines Arzneimittels zur Behandlung von Krankheiten, die mit Knochenmarködemen assoziiert sind
AR053710A1 (es) *	2005-04-11	2007-05-16	Xenon Pharmaceuticals Inc	Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
MY158766A (en) *	2005-04-11	2016-11-15	Xenon Pharmaceuticals Inc	Spiro-oxindole compounds and their uses as therapeutic agents
DK1976828T3 (en)	2005-12-29	2017-03-06	Celtaxsys Inc	DIAMINE DERIVATIVES AS INhibitors of Leukotriene A4 HYDROLASE
EP2055305A1 (en) *	2006-08-11	2009-05-06	Taisho Pharmaceutical Co. Ltd.	External preparation comprising prostaglandin derivative
US20110294842A9 (en) *	2006-10-12	2011-12-01	Xenon Pharmaceuticals Inc.	Spiro (furo [3, 2-c] pyridine-3-3' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain
RU2009117642A (ru)	2006-10-12	2010-11-20	Ксенон Фармасьютикалз Инк. (Ca)	Применение спирооксиндоловых соединений в качестве терапевтических средств
HRP20150882T1 (hr)	2008-10-17	2015-09-25	Xenon Pharmaceuticals Inc.	Spirooksindolski spojevi i njihova upotreba kao terapijska sredstva
US8101647B2 (en)	2008-10-17	2012-01-24	Xenon Pharmaceuticals Inc.	Spiro-oxindole compounds and their use as therapeutic agents
AR077252A1 (es)	2009-06-29	2011-08-10	Xenon Pharmaceuticals Inc	Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
NZ599334A (en)	2009-10-14	2014-03-28	Xenon Pharmaceuticals Inc	Synthetic methods for spiro-oxindole compounds
WO2011047173A2 (en)	2009-10-14	2011-04-21	Xenon Pharmaceuticals Inc.	Pharmaceutical compositions for oral administration
CN102946859B (zh)	2010-02-26	2016-03-02	泽农医药公司	用于局部给药的螺-羟吲哚化合物的药物组合物及其作为治疗剂的用途
KR20150002794A (ko)	2012-04-12	2015-01-07	제논 파마슈티칼스 인크.	치료제로서 유용한 스파이로-옥시인돌 화합물을 위한 비대칭적 합성
KR20150127245A (ko)	2013-03-14	2015-11-16	켈탁시스, 인코퍼레이티드	류코트라이엔 a4 가수분해효소의 저해제
AR103636A1 (es)	2015-02-05	2017-05-24	Teva Pharmaceuticals Int Gmbh	Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol
US10100060B2 (en)	2016-06-16	2018-10-16	Xenon Pharmaceuticals Inc.	Asymmetric synthesis of funapide
KR20190088551A (ko)	2016-12-09	2019-07-26	켈탁시스, 인코퍼레이티드	루코트리엔 a4 하이드롤라제의 저해제
AU2017371362A1 (en)	2016-12-09	2019-07-25	Celltaxis, Llc	Pendant amines and derivatives as inhibitors of leukotriene A4 hydrolase
AU2017371353B2 (en)	2016-12-09	2022-02-03	Celltaxis, Llc	Monamine and monoamine derivatives as inhibitors of leukotriene A4 hydrolase
HU231212B1 (hu) *	2018-04-16	2021-11-29	CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt.	Eljárás iloprost előállítására
RU2741848C1 (ru) *	2019-03-16	2021-01-29	Иванова Мария Ивановна	Способ получения клатратных комплексов летучих веществ
JP7671358B2 (ja) *	2021-09-13	2025-05-01	富士フイルム株式会社	ビシクロアルカン化合物の包摂体の製造方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS503362B1 (sv) *	1970-06-10	1975-02-04
AU476695B2 (en) *	1974-01-15	1975-07-17	Ono Pharmaceutical Co. Ltd	Clathrate prostaglandins and compositions containing same
HU179141B (sv) *	1977-09-23	1982-08-28
IT1113341B (it) *	1978-03-31	1986-01-20	Ono Pharmaceutical Co	Analoghi della 6,9-metano-pgi2
DE2845770A1 (de) *	1978-10-19	1980-04-30	Schering Ag	Neue prostacyclin-derivate und verfahren zu ihrer herstellung
DE2950027A1 (de) *	1979-12-10	1981-06-11	Schering Ag Berlin Und Bergkamen, 1000 Berlin	9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
JPS56150039A (en) *	1980-04-22	1981-11-20	Sankyo Co Ltd	Clathrate compound of prostacycline derivative
DE3126924A1 (de) *	1981-07-03	1983-01-20	Schering Ag, 1000 Berlin Und 4619 Bergkamen	9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
JPS5818357A (ja) *	1981-07-28	1983-02-02	Ono Pharmaceut Co Ltd	６，９−メタノ−ｐｇｉ↓２及び６，９−メタノ−ｐｇｉ↓２類似化合物の安定化組成物及びその製造方法
JPS58116423A (ja) *	1981-12-28	1983-07-11	Sumitomo Chem Co Ltd	メタノプロスタサイクリン製剤組成物
JPS58192821A (ja) *	1982-04-30	1983-11-10	Dainippon Pharmaceut Co Ltd	脳神経細胞の酸素欠乏性疾患の治療剤
US4517202A (en) *	1982-05-28	1985-05-14	May & Baker Limited	Prostaglandin analogues
JPS59141536A (ja) *	1983-02-01	1984-08-14	Sumitomo Chem Co Ltd	新規ビシクロオクタン誘導体
DE3306123A1 (de) *	1983-02-18	1984-09-06	Schering AG, 1000 Berlin und 4709 Bergkamen	Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
FR2547818B1 (fr) *	1983-05-24	1986-09-05	May & Baker Ltd	Nouveaux analogues de prostaglandines, leur preparation, les compositions pharmaceutiques qui les contiennent et les intermediaires-cles pour les preparer
DE3405181A1 (de) *	1984-02-10	1985-08-22	Schering AG, 1000 Berlin und 4709 Bergkamen	Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0171992B1 (en) *	1984-08-09	1990-06-06	Mitsubishi Kasei Corporation	Pharmaceuticals containing prostaglandin i2
JPS6144819A (ja) *	1984-08-09	1986-03-04	Sagami Chem Res Center	プロスタグランジンｉ２類縁化合物を含有する循環改善作用を有する薬剤
US4757087A (en) *	1985-03-19	1988-07-12	Sankyo Company Limited	Carbacyclin derivatives
DE3608088C2 (de) *	1986-03-07	1995-11-16	Schering Ag	Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten

1986
- 1986-03-07 DE DE3608088A patent/DE3608088C2/de not_active Expired - Lifetime
1987
- 1987-03-03 DD DD87300413A patent/DD258942A5/de not_active IP Right Cessation
- 1987-03-03 GB GB08704982A patent/GB2189783A/en not_active Withdrawn
- 1987-03-04 GR GR870363A patent/GR870363B/el unknown
- 1987-03-05 IL IL81802A patent/IL81802A/xx not_active IP Right Cessation
- 1987-03-05 NZ NZ219508A patent/NZ219508A/xx unknown
- 1987-03-06 ZA ZA871663A patent/ZA871663B/xx unknown
- 1987-03-06 CA CA000531395A patent/CA1309087C/en not_active Expired - Lifetime
- 1987-03-06 CS CS871511A patent/CS270558B2/cs not_active IP Right Cessation
- 1987-03-07 ES ES8700629A patent/ES2004543A6/es not_active Expired
- 1987-03-09 AU AU69886/87A patent/AU6988687A/en not_active Abandoned
- 1987-03-09 WO PCT/DE1987/000106 patent/WO1987005294A1/de not_active Ceased
- 1987-03-09 IE IE58687A patent/IE59760B1/en not_active IP Right Cessation
- 1987-03-09 AT AT0900787A patent/AT397084B/de active
- 1987-03-09 HU HU871916A patent/HU198906B/hu unknown
- 1987-03-09 EP EP87902041A patent/EP0259468B1/de not_active Expired - Lifetime
- 1987-03-09 US US07/023,506 patent/US4886788A/en not_active Expired - Lifetime
- 1987-03-09 CH CH3687/87A patent/CH672313A5/de not_active IP Right Cessation
- 1987-03-09 AU AU71609/87A patent/AU609390B2/en not_active Expired
- 1987-03-09 DE DE8787902041T patent/DE3770085D1/de not_active Expired - Lifetime
- 1987-03-09 GB GB8725695A patent/GB2199031B/en not_active Expired - Lifetime
- 1987-03-09 JP JP62501825A patent/JPH07107020B2/ja not_active Expired - Lifetime
- 1987-03-09 DE DE87DE8700106T patent/DE3790121D2/de not_active Expired
- 1987-10-07 FI FI874406A patent/FI92388C/sv not_active IP Right Cessation
- 1987-11-05 SU SU874203626A patent/SU1632371A3/ru active
- 1987-11-06 NO NO874632A patent/NO173440C/no unknown
1995
- 1995-04-24 JP JP7098975A patent/JP2634787B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO874632L (no)	1987-11-06
ATA900787A (de)	1993-06-15
CS151187A2 (en)	1989-11-14
WO1987005294A1 (fr)	1987-09-11
EP0259468B1 (de)	1991-05-15
HUT45484A (en)	1988-07-28
FI874406A0 (sv)	1987-10-07
JPH07107020B2 (ja)	1995-11-15
GB2189783A (en)	1987-11-04
NO173440C (no)	1993-12-15
GB2199031A (en)	1988-06-29
NO874632D0 (no)	1987-11-06
IL81802A (en)	1991-07-18
AU7160987A (en)	1987-09-28
JPS63502665A (ja)	1988-10-06
DE3770085D1 (de)	1991-06-20
CS270558B2 (en)	1990-07-12
DD258942A5 (de)	1988-08-10
HU198906B (en)	1989-12-28
ZA871663B (en)	1987-08-28
AT397084B (de)	1994-01-25
GB8704982D0 (en)	1987-04-08
IE870586L (en)	1987-09-07
EP0259468A1 (de)	1988-03-16
US4886788A (en)	1989-12-12
NO173440B (no)	1993-09-06
DE3608088C2 (de)	1995-11-16
GB8725695D0 (en)	1987-12-09
ES2004543A6 (es)	1989-01-16
IL81802A0 (en)	1987-10-20
JP2634787B2 (ja)	1997-07-30
DE3608088A1 (de)	1987-09-10
CH672313A5 (sv)	1989-11-15
CA1309087C (en)	1992-10-20
FI92388B (sv)	1994-07-29
DE3790121D2 (en)	1988-03-10
GR870363B (en)	1987-06-30
AU609390B2 (en)	1991-05-02
GB2199031B (en)	1990-01-10
NZ219508A (en)	1990-08-28
IE59760B1 (en)	1994-03-23
FI92388C (sv)	1994-11-10
SU1632371A3 (ru)	1991-02-28
JPH08193046A (ja)	1996-07-30
AU6988687A (en)	1987-09-10

Publication	Publication Date	Title
FI874406A7 (sv)	1987-10-07	Förfarande för framställning av terapeutiskt användbara cyklodextrinklatrat av en karbacyklinanalog
FI881180L (sv)	1988-09-14	Förfarande för framställning av terapeutiskt användbara tetrahydronaftalenderivat
FI875660L (sv)	1987-12-22	Förfarande för framställning av terapeutiskt användbara 5-fenyl-2-pyrimidinonderivat
FI885409A7 (sv)	1989-05-24	Förfarande för framställning av nya terapeutiskt användbara pyridazinaminderivat
PT86875A (pt)	1988-04-01	Process for the preparation of phenylcarbamate
PT88596A (pt)	1988-10-01	Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas
FI883388L (sv)	1989-01-18	Förfarande för framställning av nya terapeutiskt användbara peptider
FI981807L (sv)	1998-08-24	Förfarande för framställning av terapeutiskt användbara starburstkonjugat
FI872785A7 (sv)	1987-12-24	Förfarande för framställning av terapeutiskt användbara triazolföreningar
FI890286L (sv)	1989-07-21	Förfarande för framställning av terapeutiskt användbara dideoxikarbocykliska nukleosidanaloger
PT86866A (pt)	1988-03-01	Process for preparing piperazinyl-heterocyclic compounds
FI883249A7 (sv)	1989-01-11	Förfarande för framställning av terapeutiskt användbara 3-desmetylmevalonsyraderivat
FI883632L (sv)	1989-02-05	Förfarande för framställning av nya, terapeutiskt användbara etrar
FI873069A7 (sv)	1988-01-12	Förfarande för framställning av nya terapeutiskt användbara difenylpropylaminderivat
FI891074A0 (sv)	1989-03-07	Förfarande för framställning av cykliska sulfater
FI872517A7 (sv)	1987-12-07	Förfarande för framställning av terapeutiskt användbara makrolidföreningar
FI892185L (sv)	1989-05-05	Förfarande för framställning av terapeutiskt användbara peptidföreningar
FI91262B (sv)	1994-02-28	Förfarande för framställning av terapeutisk användbara LL-E33288-komplex-disulfidanalog
FI883672A7 (sv)	1989-02-08	Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat
PT87065A (pt)	1988-04-01	Process for the preparation of a vaccine against pasteurellosis
FI883661L (sv)	1989-02-09	Förfarande för framställning av företrad stärkelse
FI881525A7 (sv)	1988-10-02	Förfarande för framställning av nya terapeutiskt användbara N-arylpiperazinacetamidderivat
FI885560A7 (sv)	1988-11-30	Förfarande för framställning av nya terapeutiskt användbara bisfenylalkylpiperazinderivat
FI893003L (sv)	1989-12-21	Förfarande för framställning av terapeutiskt användbara neplanocinderivat
FI893130L (sv)	1989-12-29	Förfarande för framställning av nya terapeutiskt användbara estramustinestrar

Legal Events

Date	Code	Title	Description
1994-07-01	BB	Publication of examined application
2004-08-31	FG	Patent granted	Owner name: SCHERING AKTIENGESELLSCHAFT
2007-03-26	MA	Patent expired